Use of an influenza virus an oil-in-water emulsion adjuvant to induce CD4 T-cell and/or improved B-memory cell response

Details for Australian Patent Application No. 2006226543 (hide)

Owner GlaxoSmithKline Biologicals S.A.

Inventors Hanon, Emmanuel Jules; Stephenne, Jean

Agent Shelston IP

Pub. Number AU-B-2006226543

PCT Pub. Number WO2006/100109

Priority 0510589.5 24.05.05 GB; 0510593.7 24.05.05 GB; 0510598.6 24.05.05 GB; 0506000.9 23.03.05 GB; 0603788.1 24.02.06 GB; 0603790.7 24.02.06 GB; 0505998.5 23.03.05 GB; 0505989.4 23.03.05 GB; 0506004.1 23.03.05 GB; 0510591.1 24.05.05 GB; 0510596.0 24.05.05 GB; 0506001.7 23.03.05 GB; 0603789.9 24.02.06 GB

Filing date 21 March 2006

Wipo publication date 28 September 2006

Acceptance publication date 6 October 2011

International Classifications

A61K 39/145 (2006.01) Medicinal preparations containing antigens or antibodies - Orthomyxoviridae, e.g. influenza virus

Event Publications

4 October 2007 PCT application entered the National Phase

  PCT publication WO2006/100109 Priority application(s): WO2006/100109

6 October 2011 Application Accepted

  Published as AU-B-2006226543

2 February 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006226544-2-oxo-1,2,4,5-tetrahydro-1,3-benzodiaz epin-3-yl-piperidines used as CGRP antagonists

2006226542-Fermentation process for the production of diphtheria toxin